Literature DB >> 32860604

Bradykinin-Potentiating Activity of a Gamma-Irradiated Bioactive Fraction Isolated from Scorpion (Leiurus quinquestriatus) Venom in Rats with Doxorubicin-Induced Acute Cardiotoxicity: Favorable Modulation of Oxidative Stress and Inflammatory, Fibrogenic and Apoptotic Pathways.

Lamiaa A Ahmed1, Fatma Y Abdou2, Abir A El Fiky3, Esmat A Shaaban2, Afaf A Ain-Shoka4.   

Abstract

Although doxorubicin (Dox) is a backbone of chemotherapy, the search for an effective and safe therapy to revoke Dox-induced acute cardiotoxicity remains a critical matter in cardiology and oncology. The current study was the first to explore the probable protective effects of native and gamma-irradiated fractions with bradykinin-potentiating activity (BPA) isolated from scorpion (Leiurus quinquestriatus) venom against Dox-induced acute cardiotoxicity in rats. Native or irradiated fractions (1 μg/g) were administered intraperitoneally (i.p.) twice per week for 3 weeks, and Dox (15 mg/kg, i.p.) was administered on day 21 at 1 h after the last native or irradiated fraction treatment. Electrocardiographic (ECG) aberrations were ameliorated in the Dox-treated rats pretreated with the native fraction, and the irradiated fraction provided greater amelioration of ECG changes than that of the native fraction. The group pretreated with native protein with BPA also exhibited significant improvements in the levels of oxidative stress-related, inflammatory, angiogenic, fibrogenic, and apoptotic markers compared with those of the Dox group. Notably, the irradiated fraction restored these biomarkers to their normal levels. Additionally, the irradiated fraction ameliorated Dox-induced histological changes and alleviated the severity of cardiac injury to a greater extent than that of the native fraction. In conclusion, the gamma-irradiated detoxified fraction of scorpion venom elicited a better cardioprotective effect than that of the native fraction against Dox-induced acute cardiotoxicity in rats.

Entities:  

Keywords:  Cardiotoxicity; Doxorubicin; Gamma irradiation; Scorpion venom

Mesh:

Substances:

Year:  2020        PMID: 32860604     DOI: 10.1007/s12012-020-09602-5

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  58 in total

Review 1.  Pharmacology and cardiovascular implications of the kinin-kallikrein system.

Authors:  A Dendorfer; S Wolfrum; P Dominiak
Journal:  Jpn J Pharmacol       Date:  1999-04

2.  A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.

Authors:  S H FERREIRA
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  History of the design of captopril and related inhibitors of angiotensin converting enzyme.

Authors:  D W Cushman; M A Ondetti
Journal:  Hypertension       Date:  1991-04       Impact factor: 10.190

Review 4.  Genetic mechanisms of scorpion venom peptide diversification.

Authors:  Cao Zhijian; Luo Feng; Wu Yingliang; Mao Xin; Li Wenxin
Journal:  Toxicon       Date:  2006-01-04       Impact factor: 3.033

5.  Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis.

Authors:  Katia Conceição; Katsuhiro Konno; Robson Lopes de Melo; Marta M Antoniazzi; Carlos Jared; Juliana M Sciani; Isaltino M Conceição; Benedito C Prezoto; Antônio Carlos Martins de Camargo; Daniel C Pimenta
Journal:  Peptides       Date:  2006-11-13       Impact factor: 3.750

6.  Identification of novel bradykinin-potentiating peptides (BPPs) in the venom gland of a rattlesnake allowed the evaluation of the structure-function relationship of BPPs.

Authors:  Claudiana L Gomes; Katsuhiro Konno; Isaltino M Conceição; Danielle Ianzer; Norma Yamanouye; Benedito C Prezoto; Marina T Assakura; Gandhi Rádis-Baptista; Tetsuo Yamane; Robson A Santos; Antonio C M de Camargo; Mirian A F Hayashi
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

7.  Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom.

Authors:  A C Cintra; C A Vieira; J R Giglio
Journal:  J Protein Chem       Date:  1990-04

8.  Structure-function studies on the bradykinin potentiating peptide from Chinese snake venom (Agkistrodon halys Pallas).

Authors:  C W Chi; S Z Wang; L G Xu; M Y Wang; S S Lo; W D Huang
Journal:  Peptides       Date:  1985       Impact factor: 3.750

9.  Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs.

Authors:  Jorge Hernandez Fernandez; Goran Neshich; Antonio Carlos M Camargo
Journal:  Genet Mol Res       Date:  2004-12-30

10.  Tityus serrulatus Hypotensins: a new family of peptides from scorpion venom.

Authors:  T Verano-Braga; C Rocha-Resende; D M Silva; D Ianzer; M F Martin-Eauclaire; P E Bougis; M E de Lima; R A S Santos; A M C Pimenta
Journal:  Biochem Biophys Res Commun       Date:  2008-04-28       Impact factor: 3.575

View more
  3 in total

1.  Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats.

Authors:  Ghadha Ibrahim Fouad; Kawkab A Ahmed
Journal:  Cardiovasc Toxicol       Date:  2021-11-27       Impact factor: 3.231

2.  Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-β1/Smad Signaling Pathway.

Authors:  Yan Zhang; Liping Xu; Qiang Chen; Tianrong Guan; Na Lin; Danyang Xu; Lihong Lu; Qiaoding Dai; Xinwei Song
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-13       Impact factor: 2.650

3.  Vespakinin-M, a natural peptide from Vespa magnifica, promotes functional recovery in stroke mice.

Authors:  Hairong Zhao; Mei Wang; Yuan Gao; Xiumei Wu; Huai Xiao; Dasong Yang; Furong He; Jiaming Lv; Qiang Wang; Weidong Liu; Jingang Luo; Zizhong Yang; Chenggui Zhang; Jidong Cheng; Yu Zhao
Journal:  Commun Biol       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.